The first of these will be a quantitative test for Sepsis, the body’s extreme and life-threatening response
to infection. The delivery of effective lifesaving treatment for Sepsis is time critical, it is difficult to
diagnose Sepsis promptly and it is often missed when it could be more effectively treated, resulting in
a very high global mortality rate, significantly beyond that of COVID-19 today.1
Having looked after many septic pts being able to fast track diagnosis will save many lives...Very exciting
Ann: Test Platform and COVID-19 Test receive CE Mark approval, page-10
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.30M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $5.874K | 268.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1154535 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 299898 | 2 |
View Market Depth
| Last trade - 13.47pm 10/07/2024 (20 minute delay) ? |
| ADO (ASX) Chart |